| Cassandra E Delude, APRN | |
|
248 Pleasant St Ste 206, Concord, NH 03301-2588 | |
| (603) 230-7266 | |
| (603) 227-7554 |
| Full Name | Cassandra E Delude |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 15 Years |
| Location | 248 Pleasant St Ste 206, Concord, New Hampshire |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1861720211 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Concord Hospital | Concord, NH | Hospital |
| Lakes Region General Hospital | Laconia, NH | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Concord Hospital Inc | 6103721790 | 462 |
News Archive
Neuraltus Pharmaceuticals, a private biopharmaceutical company developing novel therapies for rare neurological disorders, announced today top-line results from the Company's Phase 2 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).
BioSante Pharmaceuticals, Inc. today announced that it has entered into an Option Agreement with an undisclosed large multi-national pharmaceutical company to obtain a non-exclusive worldwide license for the use of BioSante's 2A/Furin technology in the expression of antibodies.
According to early clinical evidence from a safety study, a new endoscopic spray from Cook Medical may offer a new surgery-free procedure for treating potentially fatal acute bleeding of peptic ulcers.
Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that Ryo Kubota, M.D., Ph.D., Acucela's chairman, president and chief executive officer, has been invited to participate in Retina International's annual Scientific & Medical Advisory Board meeting being held in Fort Lauderdale, Florida on May 3, 2010.
› Verified 6 days ago
| Entity Name | Concord Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194778571 PECOS PAC ID: 6103721790 Enrollment ID: O20040405000916 |
News Archive
Neuraltus Pharmaceuticals, a private biopharmaceutical company developing novel therapies for rare neurological disorders, announced today top-line results from the Company's Phase 2 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).
BioSante Pharmaceuticals, Inc. today announced that it has entered into an Option Agreement with an undisclosed large multi-national pharmaceutical company to obtain a non-exclusive worldwide license for the use of BioSante's 2A/Furin technology in the expression of antibodies.
According to early clinical evidence from a safety study, a new endoscopic spray from Cook Medical may offer a new surgery-free procedure for treating potentially fatal acute bleeding of peptic ulcers.
Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that Ryo Kubota, M.D., Ph.D., Acucela's chairman, president and chief executive officer, has been invited to participate in Retina International's annual Scientific & Medical Advisory Board meeting being held in Fort Lauderdale, Florida on May 3, 2010.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Cassandra E Delude, APRN 248 Pleasant St Ste 206, Concord, NH 03301-2588 Ph: (032) 307-2666 | Cassandra E Delude, APRN 248 Pleasant St Ste 206, Concord, NH 03301-2588 Ph: (603) 230-7266 |
News Archive
Neuraltus Pharmaceuticals, a private biopharmaceutical company developing novel therapies for rare neurological disorders, announced today top-line results from the Company's Phase 2 clinical study of NP001 in patients with Amyotrophic Lateral Sclerosis (ALS, or Lou Gehrig's disease).
BioSante Pharmaceuticals, Inc. today announced that it has entered into an Option Agreement with an undisclosed large multi-national pharmaceutical company to obtain a non-exclusive worldwide license for the use of BioSante's 2A/Furin technology in the expression of antibodies.
According to early clinical evidence from a safety study, a new endoscopic spray from Cook Medical may offer a new surgery-free procedure for treating potentially fatal acute bleeding of peptic ulcers.
Acucela, a clinical-stage biotechnology company focused on developing new treatments for blinding eye diseases, announced today that Ryo Kubota, M.D., Ph.D., Acucela's chairman, president and chief executive officer, has been invited to participate in Retina International's annual Scientific & Medical Advisory Board meeting being held in Fort Lauderdale, Florida on May 3, 2010.
› Verified 6 days ago
Ms. Sandra Arleigh Dinning, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 253 Pleasant St, Concord, NH 03301 Phone: 603-226-6108 | |
Ardell Currier, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-227-7140 Fax: 603-227-7187 | |
Judith Ann Ainsworth, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St, Concord, NH 03301 Phone: 603-227-7000 | |
Ms. Jennifer L Mcfadden, APRN, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 239 Pleasant St, Concord, NH 03301 Phone: 603-224-6561 | |
Janie Ann Boyle, MS, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 18 Foundry St, Suite 201, Concord, NH 03301 Phone: 603-228-0071 Fax: 603-228-7014 | |
Sara Joan Joncas, APRN, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 250 Pleasant St., Concord, NH 03301 Phone: 603-228-7200 Fax: 603-227-7562 | |
Kim Ann Eldredge, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 10 Ferry St Ste 313, Concord, NH 03301 Phone: 860-788-6404 |